Maximum gravitational-wave energy emissible in magnetar flares

Recent searches of gravitational-wave (GW) data raise the question of what maximum GW energies could be emitted during gamma-ray flares of highly magnetized neutron stars (magnetars). The highest energies (\sim 10^{49} erg) predicted so far come from a model [K. Ioka, Mon. Not. Roy. Astron. Soc. 327, 639 (2001)] in which the internal magnetic field of a magnetar experiences a global reconfiguration, changing the hydromagnetic equilibrium structure of the star and tapping the gravitational potential energy without changing the magnetic potential energy. The largest energies in this model assume very special conditions, including a large change in moment of inertia (which was observed in at most one flare), a very high internal magnetic field, and a very soft equation of state. Here we show that energies of 10^{48}-10^{49} erg are possible under more generic conditions by tapping the magnetic energy, and we note that similar energies may also be available through cracking of exotic solid cores. Current observational limits on gravitational waves from magnetar fundamental modes are just reaching these energies and will beat them in the era of advanced interferometers.Comment: 16 pages, 5 figures, 1 tabl

HOSPITAL UNIVERSITÁRIO DE SANTA MARIA: VISITA GUIADA, UMA ALTERNATIVA PARA MELHORAR O BEM ESTAR DE CRIANÇAS E ADOLESCENTES EM TRATAMENTO CONTRA O CÂNCER

O Programa de Extensão Cuidado e Atenção à Criança e Adolescente em Tratamento Oncológico - CAACTO, tem como objetivo promover a atenção integral à saúde das crianças e adolescentes em tratamento no Centro de Tratamento à Criança e ao Adolescente com Câncer –CTCriaC do Hospital Universitário de Santa Maria –HUSM, bem como a seus cuidadores e familiares na perspectiva da Política Nacional de Humanização da assistência em saúde. Entre as diversas atividades realizadas, apresentamos a Visita Guiada, que consiste um passeio pelos serviços hospitalares que prestam serviços a esses usuários. Tem como objetivo levar ao conhecimento dos pacientes e familiares o universo de pessoas e processos envolvidos no tratamento, bem como permitir que os profissionais conheçam os usuários para os quais prestam seus serviços. Partimos do pressuposto que as trocas estabelecidas contribuam para desmistificar a hospitalização, dirimir medos e ansiedade, compreender o universo de pessoas e processos envolvidos no tratamento, levando à humanização do tratamento. A dinâmica da atividade consiste em articulações e planejamento com os profissionais dos diversos setores envolvidos; seleção dos usuários elegíveis para a visita pelo médico de plantão e equipe de enfermagem, priorizando aqueles em primeira internação; organização do roteiro de visita; conversa com usuários e familiares sobre os critérios e cuidados durante a visita. Fazem parte do roteiro: Hemoterapia, Lavanderia e Sala de Costura, Farmácia Hospitalar, Nutrição e Dietética. Como resultados positivos pode-se contabilizar a humanização das relações estabelecidas entre pacientes, familiares, acadêmicos e profissionais do serviço. Valorização dos profissionais e dos serviços prestados, sensibilização dos profissionais diante das pessoas a quem atende; compreensão, por parte dos usuários e familiares, do contexto hospitalar e do tratamento; formação humanizada e interdisciplinar dos acadêmicos envolvidos

Insecticidal Activity of [Cu(H2NTA)2].2H2O in Aedes aegypti Larvae (Diptera: Culicidae)

The demand for new insecticides and alternative strategies for the population control of Aedes aegypti has stimulated research to obtain new compounds with broad biological activity. Accordingly, the dihydrogen nitrilotriacetate complex of copper (II) dihydrate, [Cu(H2NTA)2].2H2O, was synthesized by the stoichiometric reaction of nitrilotriacetic acid (H3NTA) hydroxide with basic copper carbonate (II) (Cu2(OH)2CO3) and characterized by the spectroscopic techniques UV-Vis and FT-IR. The biological toxicity in A. aegypti was determined by bioassay using concentrations ranging from 90.0 mg L−1 to 897.4 mg L−1. The LC50 obtained was 146.11 mg L−1 [132.18–160.10] and the LT50 obtained at a concentration of 897.4 mg L−1 was 70.61 min [38.21–94.90]. The results showed that the complex obtained in this work is a potential metal-insecticide. DOI: http://dx.doi.org/10.17807/orbital.v7i4.73

Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil

Background: To evaluate the determinants of intensive insulin regimens (ITs) in patients with type 1 diabetes (T1D).Methods: This multicenter study was conducted between December 2008 and December 2010 in 28 public clinics in 20 Brazilian cities. Data were obtained from 3,591 patients (56.0% female, 57.1% Caucasian). Insulin regimens were classified as follows: group 1, conventional therapy (CT) (intermediate human insulin, one to two injections daily); group 2 (three or more insulin injections of intermediate plus regular human insulin); group 3 (three or more insulin injections of intermediate human insulin plus short-acting insulin analogues); group 4, basal-bolus (one or two insulin injections of long-acting plus short-acting insulin analogues or regular insulin); and group 5, basal-bolus with continuous subcutaneous insulin infusion (CSII). Groups 2 to 5 were considered IT groups.Results: We obtained complete data from 2,961 patients. Combined intermediate plus regular human insulin was the most used therapeutic regimen. CSII was used by 37 (1.2%) patients and IT by 2,669 (90.2%) patients. More patients on IT performed self-monitoring of blood glucose and were treated at the tertiary care level compared to CT patients (p < 0.001). the majority of patients from all groups had HbA1c levels above the target. Overweight or obesity was not associated with insulin regimen. Logistic regression analysis showed that economic status, age, ethnicity, and level of care were associated with IT (p < 0.001).Conclusions: Given the prevalence of intensive treatment for T1D in Brazil, more effective therapeutic strategies are needed for long term-health benefits.Farmanguinhos/Fundacao Oswaldo Cruz/National Health MinistryBrazilian Diabetes SocietyFundacao do Amparo a Pesquisa do Estado do Rio de JaneiroConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Univ Estado Rio de Janeiro, Unit Diabet, BR-20551030 Rio de Janeiro, BrazilBaurus Diabet Assoc, São Paulo, BrazilFed Univ São Paulo State, Diabet Unit, São Paulo, BrazilFed Univ Hosp Porto Alegre, Porto Alegre, BrazilUniv Hosp São Paulo, Diabet Unit, São Paulo, BrazilUniv Fed Rio de Janeiro, Rio de Janeiro, BrazilUniv Fed Ceara, Fortaleza, Ceara, BrazilSanta Casa Misericordia, Belo Horizonte, MG, BrazilSanta Casa Misericordia São Paulo, São Paulo, BrazilUniv Fed Amazonas, Manaus, Amazonas, BrazilHosp Geral de Bonsucesso, Rio de Janeiro, BrazilHosp Univ Clementino Fraga Filho IPPMG, Rio de Janeiro, BrazilUniv Hosp São Paulo, São Paulo, BrazilFac Ciencias Med Santa Casa São Paulo, São Paulo, BrazilUniv São Paulo, Inst Crianca, Hosp Clin, São Paulo, BrazilUniv São Paulo, Fac Med Ribeirao Preto, Hosp Clin, Ribeirao Preto, BrazilAmbulatorio Fac Estadual Med Sao Jose Rio Preto, Ribeirao Preto, BrazilEscola Paulista Med, Ctr Diabet, Ribeirao Preto, BrazilClin Endocrinol Santa Casa Belo Horizonte, Belo Horizonte, MG, BrazilUniv Estadual Londrina, Londrina, BrazilUniv Fed Parana, Hosp Clin, Porto Alegre, RS, BrazilInst Crianca Com Diabet Rio Grande Sul, Rio Grande Do Sul, RS, BrazilGrp Hosp Conceicao, Inst Crianca Com Diabet, Porto Alegre, RS, BrazilHosp Univ Santa Catarina, Florianopolis, SC, BrazilInst Diabet Endocrinol Joinville, Joinville, BrazilHosp Reg Taguatinga, Brasilia, DF, BrazilHosp Geral Goiania, Goiania, Go, BrazilCtr Diabet & Endocrinol Estado Bahia, Goiania, Go, BrazilUniv Fed Maranhao, Sao Luis, BrazilCtr Integrado Diabet & Hipertensao Ceara, Fortaleza, Ceara, BrazilUniv Fed Sergipe, Aracaju, BrazilHosp Univ Alcides Carneiro, Campina Grande, BrazilHosp Univ Joao de Barros Barreto, Belem, Para, BrazilFed Univ São Paulo State, Diabet Unit, São Paulo, BrazilUniv Hosp São Paulo, Diabet Unit, São Paulo, BrazilUniv Hosp São Paulo, São Paulo, BrazilEscola Paulista Med, Ctr Diabet, Ribeirao Preto, BrazilWeb of Scienc

A Metabolomic Approach to the Study of Wine Micro-Oxygenation

Wine micro-oxygenation is a globally used treatment and its effects were studied here by analysing by untargeted LC-MS the wine metabolomic fingerprint. Eight different procedural variations, marked by the addition of oxygen (four levels) and iron (two levels) were applied to Sangiovese wine, before and after malolactic fermentation